Eudaimonia Advisors’s Organon & Co OGN Stock Holding History

Eudaimonia Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,175	Closed	-$216K	–	153
2023 Q1	$216K	Sell	9,175 -2,548	-22%	-$68.4K	0.15%	144
2022 Q4	$327K	Sell	11,723 -2,902	-20%	-$74.2K	0.22%	104
2022 Q3	$342K	Sell	14,625 -1,328	-8%	-$40.1K	0.24%	99
2022 Q2	$538K	Sell	15,953 -2,694	-14%	-$94.4K	0.37%	76
2022 Q1	$651K	Sell	18,647 -447	-2%	-$15.3K	0.37%	76
2021 Q4	$581K	Buy	+19,094	New	+$622K	0.34%	83

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Eudaimonia Advisors's OGN Position: Q2 2023 in Review

Eudaimonia Advisors sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 9,175 shares — an estimated $216K sold.

Eudaimonia Advisors first reported a position in OGN in Q4 2021 and held it in 6 quarters. The position peaked at $651K in Q1 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

Eudaimonia Advisors reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
Eudaimonia Advisors sold 9,175 Organon & Co shares in Q2 2023, an estimated $216K.
Eudaimonia Advisors first reported a position in Organon & Co in Q4 2021 and held it in 6 quarters.
Eudaimonia Advisors's Organon & Co position peaked at $651K in Q1 2022.
726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Eudaimonia Advisors's 13F filing for Q2 2023, filed 19 Jul 2023.